SCHEMBL5118324

SCHEMBL5118324

COc1cccc(CNc2c(-c3ccc(C#Cc4ccccc4)s3)nc3nc(C)ccn23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
NR1H4 Q96RI1 4/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
RECQL P46063 1/20 0.40
SALL4 Q9UJQ4 1/20 0.39
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
TP53 P04637 1/20 0.38
ADORA2A P29274 2/20 0.37
ADORA2B P29275 2/20 0.37
ADORA1 P30542 2/20 0.37
ADORA3 P0DMS8 1/20 0.36
PDE2A O00408 1/20 0.36
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5116745 0.91 NR1H4 (0.43) ALDH1A1KDM4EHPGDNR1H4NPC1
SCHEMBL5117116 0.86 NR1H4 (0.48) ALDH1A1KDM4EHPGDNR1H4NPC1
SCHEMBL5123825 0.85 MAPT (0.43) ALDH1A1KDM4EHSD17B10HPGDNR1H4
SCHEMBL5122351 0.84 SMN1; SMN2 (0.38) ALDH1A1KDM4EHSD17B10SMN1; SMN2GAA
SCHEMBL5127415 0.83 SALL4 (0.59) ALDH1A1KDM4ENR1H4NPC1RAB9A
SCHEMBL5122903 0.82 NR1H4 (0.43) ALDH1A1KDM4EHSD17B10HPGDNR1H4
SCHEMBL5122200 0.82 ATP4A (0.39) NR1H4SALL4GAATP53ADORA2A
SCHEMBL5123204 0.81 NR1H4 (0.38) ALDH1A1KDM4EHSD17B10HPGDNR1H4
SCHEMBL5122911 0.81 NR1H4 (0.44) ALDH1A1KDM4EHSD17B10HPGDNR1H4
SCHEMBL5114256 0.79 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10HPGDNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1791840-B1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS GRUENENTHAL GMBH (DE) 2013-11-27 EP claimed
US-7420056-B2 Substituted bicyclic imidazo-3-ylamine compounds GRUENENTHAL GMBH (DE) 2008-09-02 US claimed
US-20070155965-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS GRUENENTHAL GMBH. (DE) 2007-07-05 US claimed
EP-1791840-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2007-06-06 EP claimed
WO-2006029980-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2006-03-23 WO claimed
US-7420056-B2 Substituted bicyclic imidazo-3-ylamine compounds GRUENENTHAL GMBH (DE) 2008-09-02 US disclosed
US-20070155965-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS GRUENENTHAL GMBH. (DE) 2007-07-05 US disclosed
EP-1791840-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2007-06-06 EP disclosed
WO-2006029980-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155965-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS AADAC, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAICS ALDH1A1 2777/4885KDM4E 1336/4885HSD17B10 3688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.